| Q33831794 | A comprehensive look at transcription factor gene expression changes in colorectal adenomas |
| Q41287485 | A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor |
| Q37141016 | A naturally hypersensitive glucocorticoid receptor elicits a compensatory reduction of hypothalamus-pituitary-adrenal axis activity early in ontogeny |
| Q36563339 | A trilogy of glucocorticoid receptor actions |
| Q38930984 | Addressing corticosteroid insensitivity in adults with asthma |
| Q42073494 | An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics |
| Q37591810 | An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti- and proinflammatory effector genes. |
| Q39134573 | Anti- trachea inflammatory effects of diosgenin from Dioscorea nipponica through interactions with glucocorticoid receptor α. |
| Q38219189 | Assessing herbal products with health claims |
| Q47623306 | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double-Blind, Randomized, Placebo-Controlled Phase 1 Clinical Study |
| Q33613763 | Bronchial epithelial cells are rendered insensitive to glucocorticoid transactivation by transforming growth factor-β1. |
| Q38941483 | Challenges to develop novel anti-inflammatory and analgesic drugs |
| Q37066464 | Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory Effects |
| Q33658855 | Comparing the rules of engagement of androgen and glucocorticoid receptors |
| Q37653249 | Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation |
| Q61449210 | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages |
| Q38512587 | Corticosteroid use in neuro-oncology: an update |
| Q36327289 | Corticosteroids: Mechanisms of Action in Health and Disease |
| Q55340271 | Cryptic glucocorticoid receptor-binding sites pervade genomic NF-κB response elements. |
| Q38915978 | Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands |
| Q37126655 | DNA binding triggers tetramerization of the glucocorticoid receptor in live cells |
| Q38237635 | Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ. |
| Q26799423 | Dexamethasone intravitreal implant in the treatment of diabetic macular edema |
| Q39157135 | Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile |
| Q40139744 | Effects of Aspergillus fumigatus on glucocorticoid receptor and β2-adrenergic receptor expression in a rat model of asthma |
| Q38119024 | Emerging therapies in allergic conjunctivitis and dry eye syndrome |
| Q38929405 | Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation |
| Q36467010 | Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression |
| Q36628635 | Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. |
| Q64103107 | Extensive epigenomic integration of the glucocorticoid response in primary human monocytes and in vitro derived macrophages |
| Q92800308 | Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor |
| Q37121905 | Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells |
| Q92405217 | GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life |
| Q36563336 | GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression |
| Q39637172 | Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression |
| Q39173501 | Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance |
| Q34048336 | Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages. |
| Q92947178 | Glucocorticoid receptor modulators CpdX and CpdX-D3 exhibit the same in vivo antiinflammatory activities as synthetic glucocorticoids |
| Q92133568 | Glucocorticoid receptor quaternary structure drives chromatin occupancy and transcriptional outcome |
| Q26828358 | Glucocorticoid receptor signaling in health and disease |
| Q38742875 | Glucocorticoid receptors: finding the middle ground |
| Q34562459 | Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms |
| Q61804779 | Glucocorticoid-driven transcriptomes in human airway epithelial cells: commonalities, differences and functional insight from cell lines and primary cells |
| Q28077040 | Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy |
| Q38673357 | Glucocorticoid-induced leucine zipper (GILZ) in immuno suppression: master regulator or bystander? |
| Q36563476 | Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex |
| Q38555471 | Glucocorticoids and Cancer. |
| Q35023017 | Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. |
| Q33707852 | Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils |
| Q42856004 | Identification of a selective glucocorticoid receptor ligand for the treatment of chronic inflammation in type 2 diabetes mellitus |
| Q49242002 | Impact of prenatal cold stress on placental physiology, inflammatory response, and apoptosis in rats |
| Q38154624 | Inhaled corticosteroids for asthma: on-demand or continuous use. |
| Q33361175 | Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations |
| Q38835027 | Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer |
| Q35123866 | Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor |
| Q89356186 | Long-Acting β2-Adrenoceptor Agonists Enhance Glucocorticoid Receptor (GR)-Mediated Transcription by Gene-Specific Mechanisms Rather Than Generic Effects via GR |
| Q48105513 | Long-acting β2-agonists promote glucocorticoid-mediated repression of NF-κB by enhancing expression of the feedback regulator TNFAIP3. |
| Q33773081 | Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model |
| Q40816092 | Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy |
| Q38721980 | Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. |
| Q47289880 | Molecular dynamics simulations of the glucocorticoid receptor DNA-binding domain suggest a role of the lever-arm mobility in transcriptional output. |
| Q37613618 | More than meets the dimer: What is the quaternary structure of the glucocorticoid receptor? |
| Q90099983 | Nascent transcript analysis of glucocorticoid crosstalk with TNF defines primary and cooperative inflammatory repression |
| Q35834992 | Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS. |
| Q36252920 | New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma |
| Q26765156 | New dimension of glucocorticoids in cancer treatment |
| Q42218200 | Non-canonical Glucocorticoid Receptor Transactivation of gilz by Alcohol Suppresses Cell Inflammatory Response |
| Q38570469 | Novel glucocorticoid receptor agonists in the treatment of asthma |
| Q26830948 | One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids |
| Q42617579 | Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate |
| Q38200416 | Our stolen figures: the interface of sexual differentiation, endocrine disruptors, maternal programming, and energy balance |
| Q47162654 | PTGDR gene expression and response to dexamethasone treatment in an in vitro model. |
| Q28083987 | Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases |
| Q36255835 | Protective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation. |
| Q40584191 | Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma. |
| Q41365375 | Role and regulation of MKP-1 in airway inflammation. |
| Q36122756 | Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids. |
| Q34413270 | Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone. |
| Q26825916 | Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds |
| Q37470723 | Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1. |
| Q38843487 | Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner |
| Q38430684 | Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes. |
| Q33854747 | The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease |
| Q36888160 | The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. |
| Q92916721 | The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids |
| Q38050401 | The multiple facets of glucocorticoid action in rheumatoid arthritis |
| Q57169333 | The nuclear receptor superfamily: A structural perspective |
| Q50186746 | The role of microRNAs in glucocorticoid action. |
| Q27003938 | The structure, function and evolution of proteins that bind DNA and RNA |
| Q35860995 | Thiobenzothiazole-modified Hydrocortisones Display Anti-inflammatory Activity with Reduced Impact on Islet β-Cell Function |
| Q50892165 | Transendothelial movement of adiponectin is restricted by glucocorticoids. |
| Q38959067 | Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update |
| Q92881077 | Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function |